Accretion Nutraveda Ltd Financials
Company Logo

Accretion Nutraveda Ltd Financial Statement

Accretion Nutraveda Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Accretion Nutraveda Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual16.00
Operating Expenses Annual12.28
Operating Profit Annual3.78
Interest Annual0.35
Depreciation0.24
Net Profit Annual2.61
Tax Annual0.57

Accretion Nutraveda Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.12
Cash Flow from Operations-2.21
Cash Flow from Investing-0.87
Cash Flow from Financing2.98
Cash Flow at the End0.02

Accretion Nutraveda Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)23.56
PBIT Margin (%)22.06
PBT Margin (%)-41.00
Net PROFIT Margin (%)16.31
Return On Networth / Equity (%)81.18
Return On Networth /Employed (%)56.66
Return On Assets (%)41.92
Total Debt / Equity (X)0.94
Asset Turnover Ratio (%)2.57

Accretion Nutraveda Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual2.02
Total Current Assets Annual8.85
Non Current Assets Annual2.02
Total Shareholders Funds Annual5.35
Total Assets Annual10.86

Accretion Nutraveda Ltd Earning Calls

No Data Availabe

FAQS on Accretion Nutraveda Ltd Financials

As of Feb 7, 2026, Accretion Nutraveda Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Accretion Nutraveda Ltd is not with a debt-to-equity ratio of 0.72.

In FY 2025 , Accretion Nutraveda Ltd recorded a total revenue of approximately 16 Cr marking a significant milestone in the company's financial performance.

Accretion Nutraveda Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.9% annually, respectively..

Accretion Nutraveda Ltd's current PE ratio is .

Accretion Nutraveda Ltd's ROCE averaged 31.7% from the FY ending March 2023 to 2025, with a median of 35.4%. It peaked at 38.4% in March 2025, reflecting strong capital efficiency over the period..

Accretion Nutraveda Ltd's latest EBIT is Rs. 3.53 Cr, surpassing the average EBIT of Rs. 1.72 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions